Cardiovascular Inflammation
Prevalence: hs-CRP >2 mg/L present in ~25% of US adults
Evidence-Ranked Ingredients
About
Chronic low-grade systemic inflammation measured by hs-CRP, now recognized as an independent cardiovascular risk factor. The CANTOS trial validated the inflammatory hypothesis of atherosclerosis by showing reducing inflammation (IL-1beta) without affecting lipids reduced cardiovascular events.
Common Symptoms
Risk Factors
- Obesity (visceral adiposity)
- Metabolic syndrome
- Periodontal disease
- Autoimmune conditions
- Smoking
- Sedentary lifestyle
- Poor diet
Frequently Asked Questions
What supplements may help with Cardiovascular Inflammation?
How is the evidence for Cardiovascular Inflammation supplements graded?
How many studies on Cardiovascular Inflammation supplements have been reviewed?
What are common symptoms of Cardiovascular Inflammation?
Related Conditions
Conditions that share studied ingredients
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.